Epigenetic Reprogramming in Relapse/Refractory AML
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
New Approaches to Neuroblastoma Therapy Consortium
University of Washington
Kyowa Kirin Co., Ltd.
National Cancer Institute (NCI)
The University of Texas Health Science Center at San Antonio
National Cancer Institute (NCI)
University of Pittsburgh
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
New Approaches to Neuroblastoma Therapy Consortium
Hackensack Meridian Health
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Fox Chase Cancer Center
Columbia University
Yale University
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Albert Einstein College of Medicine
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
University of Wisconsin, Madison
University of Washington
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Indiana University
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)